Dr. Liauw on RT Advancements in Prostate Cancer

Stanley Liauw, MD
Published: Thursday, Sep 15, 2016


Stanley Liauw, MD, associate professor at the University of Chicago Medicine, discusses the advancements in radiation therapy (RT) over the last several years, and how he has seen the treatment affect his patients.

There have been several innovations with prostate cancer in the last 20 years, mainly with improvements in hardware and software, Liauw explains. Previously, radiation oncologists would affix lead blocks to the heads of linear accelerators. Over time, developments allowed oncologists to reshape fields and have multiple field shapes through a beam angle to deliver a more sophisticated RT plan to patients.

In practice, Liauw has observed improvements in disease control rates and quality of life, as well as decreases in prostate-specific antigen failures.
SELECTED
LANGUAGE

Stanley Liauw, MD, associate professor at the University of Chicago Medicine, discusses the advancements in radiation therapy (RT) over the last several years, and how he has seen the treatment affect his patients.

There have been several innovations with prostate cancer in the last 20 years, mainly with improvements in hardware and software, Liauw explains. Previously, radiation oncologists would affix lead blocks to the heads of linear accelerators. Over time, developments allowed oncologists to reshape fields and have multiple field shapes through a beam angle to deliver a more sophisticated RT plan to patients.

In practice, Liauw has observed improvements in disease control rates and quality of life, as well as decreases in prostate-specific antigen failures.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Current Perspectives on Preventing and Managing Tumor Lysis SyndromeJun 30, 20191.0
Community Practice Connections™: 2nd Annual International Congress on Oncology Pathology™Aug 31, 20191.5
Publication Bottom Border
Border Publication
x